Publications by authors named "G Lamichhane"

, a leading non-tuberculous mycobacterium (NTM) pathogen, causes chronic pulmonary infections, particularly in individuals with underlying lung conditions or immunosuppression. Current treatments involve prolonged multi-drug regimens with poor outcomes and significant side effects, highlighting the urgent need for improved therapies. Using a BALB/c mouse model of chronic pulmonary disease, we evaluated the efficacy of individual antibiotics-clarithromycin, clofazimine, and rifabutin-and combination regimens including clarithromycin+bedaquiline and clarithromycin+clofazimine+bedaquiline.

View Article and Find Full Text PDF

( ) is the causative agent of tuberculosis (TB), the leading cause of infectious-disease related deaths worldwide. TB infections present as a spectrum from active to latent disease. In the human host, faces hostile environments, such as nutrient deprivation, hypoxia, and low pH.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses an opportunistic pathogen that commonly affects individuals with lung issues and weakened immune systems, noting that there are no FDA-approved treatments and a high failure rate for current options.
  • It introduces MRX-6038, an intravenous oxaborole that is effective against this pathogen, and presents MRX-5, its oral prodrug, as a subject of study.
  • Results from the study demonstrated that MRX-5 showed effective results in a mouse model, with doses of 15 and 45 mg/kg performing similarly to standard treatments, indicating potential for clinical trials.
View Article and Find Full Text PDF

18KHT01 is a novel synergistic composition of , , , and a small portion of . Our previous report demonstrated that the 18KHT01 exhibits potent antiobesity effects, with synergistic antioxidant, antiadipogenic, and antiobesity activities in diet-induced obese mice. This study explores the toxicity profile and quality control parameters of the 18KHT01 formulation.

View Article and Find Full Text PDF

Infection prevention and control (IPC) is essential in nursing practice to safeguard patient health and reduce healthcare-associated infections. This article explores IPC strategies, including hand hygiene, the use of personal protective equipment, environmental cleaning, safe injection practices, and antimicrobial stewardship. It discusses the implementation challenges and solutions, such as ensuring compliance through education, monitoring and strong leadership.

View Article and Find Full Text PDF